2.06
-0.025(-1.20%)
Currency In USD
Address
75 State Street
Boston, MA 02109
United States of America
Phone
617 213 5054
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
April 29, 2022
| Name | Title | Pay | Year Born |
| Dr. Robert M. Hershberg M.D., Ph.D. | Co-Founder, President, Chief Executive Officer & Chairman of the Board | 694,506 | 1962 |
| Mr. Shane A. Maltbie | Chief Financial Officer & Treasurer | 512,375 | 1982 |
| Dr. Aditya Kohli Ph.D. | Co-Founder & Director | 1.13M | 1988 |
| Mr. Paul S. Bavier J.D. | General Counsel, Secretary & Chief Administrative Officer | 0 | 1972 |
| Dr. Anju Chatterji Ph.D. | Chief Technology Officer | 0 | N/A |
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.